MedTrace Logo

Guided Imagery of the Gynecological Cancer

NCT07408349 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-02-13

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to evaluate the effectiveness of a guided imagery intervention in women receiving chemotherapy for gynecological cancers at Başkent University Ankara Hospital Outpatient Chemotherapy Unit.

The main questions it aims to answer are:

Does guided imagery improve psychological or physical outcomes during chemotherapy? How do outcomes differ between the intervention (guided imagery) and control (standard information) groups?

Researchers will compare both groups to assess the effect of guided imagery across three repeated measurements.

Participants will:

* Be randomly assigned (1:1) to intervention or control groups via an online randomization tool.
* Complete outcome assessments at three time points.
* Be part of a sample of 158 women (minimum 76 per group), based on power analysis for repeated measures ANOVA (effect size f = 0.25, 95% power, 95% confidence).

The study will follow the CONSORT-Outcomes 2022 guideline and be registered at ClinicalTrials.gov.

Conditions

  • Gynecologic Cancer

Interventions

BEHAVIORAL

guided imagery

Guided imagery is a method of mind-body communication, fundamentally defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way our mind encodes, stores, and retrieves information. It is based on the understanding that the body and mind are interconnected and that the mind can influence the body. Stress and anxiety directly affect the brain and immune system

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Hatice Kübra YURDAKUL, Msc · Baskent University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-19
Primary Completion
2026-06-10
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07408349 on ClinicalTrials.gov